A video based benchmark data set (ENDOTEST) to evaluate computer-aided polyp detection systems.


Journal

Scandinavian journal of gastroenterology
ISSN: 1502-7708
Titre abrégé: Scand J Gastroenterol
Pays: England
ID NLM: 0060105

Informations de publication

Date de publication:
Nov 2022
Historique:
pubmed: 15 6 2022
medline: 16 11 2022
entrez: 14 6 2022
Statut: ppublish

Résumé

Computer-aided polyp detection (CADe) may become a standard for polyp detection during colonoscopy. Several systems are already commercially available. We report on a video-based benchmark technique for the first preclinical assessment of such systems before comparative randomized trials are to be undertaken. Additionally, we compare a commercially available CADe system with our newly developed one. ENDOTEST consisted in the combination of two datasets. The validation dataset contained 48 video-snippets with 22,856 manually annotated images of which 53.2% contained polyps. The performance dataset contained 10 full-length screening colonoscopies with 230,898 manually annotated images of which 15.8% contained a polyp. Assessment parameters were accuracy for polyp detection and time delay to first polyp detection after polyp appearance (FDT). Two CADe systems were assessed: a commercial CADe system (GI-Genius, Medtronic), and a self-developed new system (ENDOMIND). The latter being a convolutional neuronal network trained on 194,983 manually labeled images extracted from colonoscopy videos recorded in mainly six different gastroenterologic practices. On the ENDOTEST, both CADe systems detected all polyps in at least one image. The per-frame sensitivity and specificity in full colonoscopies was 48.1% and 93.7%, respectively for GI-Genius; and 54% and 92.7%, respectively for ENDOMIND. Median FDT of ENDOMIND with 217 ms (Inter-Quartile Range(IQR)8-1533) was significantly faster than GI-Genius with 1050 ms (IQR 358-2767, Our benchmark ENDOTEST may be helpful for preclinical testing of new CADe devices. There seems to be a correlation between a shorter FDT with a higher sensitivity and a lower specificity for polyp detection.

Sections du résumé

BACKGROUND AND AIMS
Computer-aided polyp detection (CADe) may become a standard for polyp detection during colonoscopy. Several systems are already commercially available. We report on a video-based benchmark technique for the first preclinical assessment of such systems before comparative randomized trials are to be undertaken. Additionally, we compare a commercially available CADe system with our newly developed one.
METHODS
ENDOTEST consisted in the combination of two datasets. The validation dataset contained 48 video-snippets with 22,856 manually annotated images of which 53.2% contained polyps. The performance dataset contained 10 full-length screening colonoscopies with 230,898 manually annotated images of which 15.8% contained a polyp. Assessment parameters were accuracy for polyp detection and time delay to first polyp detection after polyp appearance (FDT). Two CADe systems were assessed: a commercial CADe system (GI-Genius, Medtronic), and a self-developed new system (ENDOMIND). The latter being a convolutional neuronal network trained on 194,983 manually labeled images extracted from colonoscopy videos recorded in mainly six different gastroenterologic practices.
RESULTS
On the ENDOTEST, both CADe systems detected all polyps in at least one image. The per-frame sensitivity and specificity in full colonoscopies was 48.1% and 93.7%, respectively for GI-Genius; and 54% and 92.7%, respectively for ENDOMIND. Median FDT of ENDOMIND with 217 ms (Inter-Quartile Range(IQR)8-1533) was significantly faster than GI-Genius with 1050 ms (IQR 358-2767,
CONCLUSIONS
Our benchmark ENDOTEST may be helpful for preclinical testing of new CADe devices. There seems to be a correlation between a shorter FDT with a higher sensitivity and a lower specificity for polyp detection.

Identifiants

pubmed: 35701020
doi: 10.1080/00365521.2022.2085059
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1397-1403

Auteurs

Daniel Fitting (D)

Interventional and Experimental Endoscopy (InExEn), Internal Medicine II, University Hospital Wuerzburg, Würzburg, Germany.

Adrian Krenzer (A)

Interventional and Experimental Endoscopy (InExEn), Internal Medicine II, University Hospital Wuerzburg, Würzburg, Germany.
Artificial Intelligence and Knowledge Systems, Institute for Computer Science, Julius-Maximilians-Universität, Würzburg, Germany.

Joel Troya (J)

Interventional and Experimental Endoscopy (InExEn), Internal Medicine II, University Hospital Wuerzburg, Würzburg, Germany.

Michael Banck (M)

Interventional and Experimental Endoscopy (InExEn), Internal Medicine II, University Hospital Wuerzburg, Würzburg, Germany.
Artificial Intelligence and Knowledge Systems, Institute for Computer Science, Julius-Maximilians-Universität, Würzburg, Germany.

Boban Sudarevic (B)

Interventional and Experimental Endoscopy (InExEn), Internal Medicine II, University Hospital Wuerzburg, Würzburg, Germany.
Department of Internal Medicine and Gastroenterology, Katharinenhospital, Stuttgart, Germany.

Markus Brand (M)

Interventional and Experimental Endoscopy (InExEn), Internal Medicine II, University Hospital Wuerzburg, Würzburg, Germany.

Wolfgang Böck (W)

Practice for gastroenterology, Ulm, Germany.

Wolfram G Zoller (WG)

Department of Internal Medicine and Gastroenterology, Katharinenhospital, Stuttgart, Germany.

Thomas Rösch (T)

Department of Interdisciplinary Endoscopy, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

Frank Puppe (F)

Artificial Intelligence and Knowledge Systems, Institute for Computer Science, Julius-Maximilians-Universität, Würzburg, Germany.

Alexander Meining (A)

Interventional and Experimental Endoscopy (InExEn), Internal Medicine II, University Hospital Wuerzburg, Würzburg, Germany.

Alexander Hann (A)

Interventional and Experimental Endoscopy (InExEn), Internal Medicine II, University Hospital Wuerzburg, Würzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH